Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT Meeting Abstract

  

Authors:	Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; Papadopoulos, E.; Pinana, J. L.; Fox, M. L.; Valcarcel, D.; Solano, C.; Caballero, D.; Sierra, J.; Perales, M. A.
Abstract Title:	Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT
Meeting Title:	42nd Annual Meeting of the European Society for Blood and Marrow Transplantation
Journal Title:	Bone Marrow Transplantation
Volume:	51
Issue:	Suppl. 1
Meeting Dates:	2016 Apr 3-6
Meeting Location:	Valencia, Spain
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2016-03-01
Start Page:	S436
End Page:	S437
Language:	English
ACCESSION:	WOS:000373357601231
PROVIDER:	wos
PUBMED:	26999539
DOI:	10.1038/bmt.2016.49
Notes:	Meeting Abstract: P605 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/94330